Assignee
AGIOS PHARMACEUTICALS INC
US·78 granted patents·43 pending applications·398 citations·filing 2013–2025
Top patents by PatentIndex Score
121 records- 0197US11040036B2Pyruvate kinase activators for use in treating blood disordersAGIOS PHARMACEUTICALS INC·Filed 2020·Granted Jun 22, 2021·7 cites·26 claims
- 0297US9850277B2Therapeutically active compositions and their methods of useAGIOS PHARMACEUTICALS INC·Filed 2016·Granted Dec 26, 2017·22 cites·16 claims
- 0397US9682080B2Pyruvate kinase activators for use in therapyAGIOS PHARMACEUTICALS INC·Filed 2015·Granted Jun 20, 2017·10 cites·30 claims
- 0497US9579324B2Therapeutically active compounds and their methods of useAGIOS PHARMACEUTICALS INC·Filed 2014·Granted Feb 28, 2017·22 cites·6 claims
- 0597US9512107B2Therapeutically active compositions and their methods of useAGIOS PHARMACEUTICALS INC·Filed 2016·Granted Dec 6, 2016·25 cites·9 claims
- 0696US11793806B2Pyruvate kinase activators for use in therapyAGIOS PHARMACEUTICALS INC·Filed 2021·Granted Oct 24, 2023·3 cites·15 claims
- 0796US10800782B2Inhibitors of cellular metabolic processesAGIOS PHARMACEUTICALS INC·Filed 2018·Granted Oct 13, 2020·8 cites·42 claims
- 0896US10029987B2Therapeutic compounds and compositionsAGIOS PHARMACEUTICALS INC·Filed 2017·Granted Jul 24, 2018·9 cites·24 claims
- 0996US9656999B2Therapeutically active compounds and their methods of useAGIOS PHARMACEUTICALS INC·Filed 2016·Granted May 23, 2017·16 cites·4 claims
- 1096US9474779B2Therapeutically active compositions and their methods of useAGIOS PHARMACEUTICALS INC·Filed 2013·Granted Oct 25, 2016·36 cites·18 claims
- 1195US10632114B2Pyruvate kinase activators for use in therapyAGIOS PHARMACEUTICALS INC·Filed 2018·Granted Apr 28, 2020·6 cites·12 claims
- 1295US10172864B2Therapeutically active compounds and their methods of useAGIOS PHARMACEUTICALS INC·Filed 2016·Granted Jan 8, 2019·8 cites·21 claims
- 1395US9980961B2Pyruvate kinase activators for use in therapyAGIOS PHARMACEUTICALS INC·Filed 2017·Granted May 29, 2018·8 cites·24 claims
- 1495US9968595B2Pharmaceutical compositions of therapeutically active compoundsAGIOS PHARMACEUTICALS INC·Filed 2015·Granted May 15, 2018·17 cites·22 claims
- 1595US9751863B2Therapeutically active compounds and their methods of useAGIOS PHARMACEUTICALS INC·Filed 2016·Granted Sep 5, 2017·13 cites·17 claims
- 1694US11325914B1Inhibitors of cellular metabolic processesAGIOS PHARMACEUTICALS INC·Filed 2020·Granted May 10, 2022·2 cites·25 claims
- 1794US10610125B2Methods and compositions for cell-proliferation-related disordersAGIOS PHARMACEUTICALS INC·Filed 2017·Granted Apr 7, 2020·9 cites·12 claims
- 1894US9732062B2Therapeutically active compounds and their methods of useAGIOS PHARMACEUTICALS INC·Filed 2013·Granted Aug 15, 2017·18 cites·6 claims
- 1993US10329298B2Inhibitors of cellular metabolic processesAGIOS PHARMACEUTICALS INC·Filed 2017·Granted Jun 25, 2019·11 cites·32 claims
- 2093US9738625B2Therapeutically active compounds and their methods of useAGIOS PHARMACEUTICALS INC·Filed 2014·Granted Aug 22, 2017·16 cites·20 claims
- 2193US9694013B2Therapeutically active compounds and their methods of useAGIOS PHARMACEUTICALS INC·Filed 2015·Granted Jul 4, 2017·14 cites·17 claims
- 2292US9458132B2Therapeutic compounds and compositions and their use as PKM2 modulatorsAGIOS PHARMACEUTICALS INC·Filed 2013·Granted Oct 4, 2016·18 cites·25 claims
- 2390US10730854B2Therapeutically active compounds and their methods of useAGIOS PHARMACEUTICALS INC·Filed 2018·Granted Aug 4, 2020·3 cites·72 claims
- 2490US10294215B2Therapeutically active compounds and their methods of useAGIOS PHARMACEUTICALS INC·Filed 2017·Granted May 21, 2019·6 cites·32 claims
- 2590US10028961B2Therapeutically active compounds and their methods of useAGIOS PHARMACEUTICALS INC·Filed 2016·Granted Jul 24, 2018·4 cites·9 claims
- 2689US12428376B2Therapeutic compounds and compositionsAGIOS PHARMACEUTICALS INC·Filed 2023·Granted Sep 30, 2025·0 cites·5 claims
- 2789US11464775B2Pyruvate kinase modulators and use thereofAGIOS PHARMACEUTICALS INC·Filed 2018·Granted Oct 11, 2022·3 cites·21 claims
- 2889US2025144093A1Pyruvate kinase activators for use in treating blood disordersAGIOS PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 2988US11919915B2Compounds and methods useful for stabilizing phenylalanine hydroxylase mutationsAGIOS PHARMACEUTICALS INC·Filed 2023·Granted Mar 5, 2024·1 cites·30 claims
- 3088US11364240B2Pyruvate kinase activators for use in treating blood disordersAGIOS PHARMACEUTICALS INC·Filed 2018·Granted Jun 21, 2022·4 cites·27 claims
- 3188US10905692B2Combination therapy for treating malignanciesAGIOS PHARMACEUTICALS INC·Filed 2016·Granted Feb 2, 2021·3 cites·22 claims
- 3288US10201543B2Therapeutically active compounds and their methods of useAGIOS PHARMACEUTICALS INC·Filed 2016·Granted Feb 12, 2019·6 cites·20 claims
- 3388US9982309B2Method for treating cell proliferation related disordersAGIOS PHARMACEUTICALS INC·Filed 2016·Granted May 29, 2018·3 cites·14 claims
- 3488US9889137B2Therapeutically active compounds and their methods of useAGIOS PHARMACEUTICALS INC·Filed 2017·Granted Feb 13, 2018·6 cites·8 claims
- 3588US2025332161A1Pyruvate kinase activators for use in therapyAGIOS PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 3687US12377093B2Pyruvate kinase activators for use in therapyAGIOS PHARMACEUTICALS INC·Filed 2023·Granted Aug 5, 2025·0 cites·16 claims
- 3787US11254652B2Crystalline forms of N-(4-(4-(cyclopropymethyl)piperazine-1-carbonyl)phenyl)quinoline-8-sulfonamideAGIOS PHARMACEUTICALS INC·Filed 2018·Granted Feb 22, 2022·5 cites·8 claims
- 3887US10717764B2Therapeutically active compounds and their methods of useAGIOS PHARMACEUTICALS INC·Filed 2019·Granted Jul 21, 2020·1 cites·2 claims
- 3987US10449184B2Pharmaceutical compositions of therapeutically active compoundsAGIOS PHARMACEUTICALS INC·Filed 2018·Granted Oct 22, 2019·4 cites·23 claims
- 4086US11505538B1Therapeutically active compounds and their methods of useAGIOS PHARMACEUTICALS INC·Filed 2020·Granted Nov 22, 2022·1 cites·8 claims
- 4186US10780093B2Methods of treating brain tumors using combination therapyAGIOS PHARMACEUTICALS INC·Filed 2018·Granted Sep 22, 2020·3 cites·29 claims
- 4286US9724350B2N,6-bis(aryl or heteroaryl)-1,3,5-triazine-2,4-diamine compounds as IDH2 mutants inhibitors for the treatment of cancerAGIOS PHARMACEUTICALS INC·Filed 2014·Granted Aug 8, 2017·12 cites·14 claims
- 4385US10093654B2Therapeutically active compounds and their methods of useAGIOS PHARMACEUTICALS INC·Filed 2017·Granted Oct 9, 2018·3 cites·70 claims
- 4484US12133853B2Pyruvate kinase activators for use in treating blood disordersAGIOS PHARMACEUTICALS INC·Filed 2023·Granted Nov 5, 2024·0 cites·25 claims
- 4584US10434105B2Therapeutically active compounds and their methods of useAGIOS PHARMACEUTICALS INC·Filed 2018·Granted Oct 8, 2019·3 cites·12 claims
- 4683US10640534B2Therapeutically active compositions and their methods of useAGIOS PHARMACEUTICALS INC·Filed 2017·Granted May 5, 2020·2 cites·6 claims
- 4783US10188656B2Methods of treatment of malignanciesAGIOS PHARMACEUTICALS INC·Filed 2016·Granted Jan 29, 2019·4 cites·8 claims
- 4883US10017495B2Therapeutically active compounds and their methods of useAGIOS PHARMACEUTICALS INC·Filed 2014·Granted Jul 10, 2018·3 cites·17 claims
- 4981US11957680B2Pyruvate kinase activators for use in treating blood disordersAGIOS PHARMACEUTICALS INC·Filed 2022·Granted Apr 16, 2024·0 cites·14 claims
- 5080US10105369B2Therapeutically active compounds and their methods of useAGIOS PHARMACEUTICALS INC·Filed 2018·Granted Oct 23, 2018·2 cites·24 claims
Showing the top 50 of 121 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →